Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Monk

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Drugs|May 1, 1987
Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertensionS Titmarsh, J P Monk
Drugs|May 1, 1990
Inhaled pentamidine. An overview of its pharmacological properties and a review of its therapeutic use in Pneumocystis carinii pneumoniaJ P Monk, P Benfield
Drugs|July 1, 1987
Anisoylated plasminogen streptokinase activator complex (APSAC). A review of its mechanism of action, clinical pharmacology and therapeutic use in acute myocardial infarctionJ P Monk, R C Heel
Drugs|November 1, 1987
Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer diseaseK L Goa, J P Monk
Journal of Clinical and Hospital Pharmacy|September 1, 1982
The effect of food on the absorption of phenylbutazone from a commercial 100 mg enteric-coated tabletV A John, J P Monk
Drugs|June 1, 1987
Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemiaJ P Monk, P A Todd
Drugs|January 1, 1987
Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer diseaseJ P Monk, S P Clissold
Drugs|September 1, 1990
Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmiasJ P Monk, R N Brogden
Drugs|July 1, 1988
Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic useJ M Henwood, J P Monk
Drugs|October 1, 1991
Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycosesJ P Monk, R N Brogden
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Drugs|May 1, 1987
Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertensionS Titmarsh, J P Monk
Drugs|May 1, 1990
Inhaled pentamidine. An overview of its pharmacological properties and a review of its therapeutic use in Pneumocystis carinii pneumoniaJ P Monk, P Benfield
Drugs|July 1, 1987
Anisoylated plasminogen streptokinase activator complex (APSAC). A review of its mechanism of action, clinical pharmacology and therapeutic use in acute myocardial infarctionJ P Monk, R C Heel
Drugs|November 1, 1987
Enprostil. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer diseaseK L Goa, J P Monk
Journal of Clinical and Hospital Pharmacy|September 1, 1982
The effect of food on the absorption of phenylbutazone from a commercial 100 mg enteric-coated tabletV A John, J P Monk
Drugs|June 1, 1987
Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemiaJ P Monk, P A Todd
Drugs|January 1, 1987
Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer diseaseJ P Monk, S P Clissold
Drugs|September 1, 1990
Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmiasJ P Monk, R N Brogden
Drugs|July 1, 1988
Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic useJ M Henwood, J P Monk
Drugs|October 1, 1991
Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycosesJ P Monk, R N Brogden
Pageof 2